IP licensing and business: Oct. 9-Oct. 22

Drugmakers struck licensing deals for cancer and metabolic treatments, while technology companies broadened agreements covering mobile communications, wireless charging and AI infrastructure, and Nokia saw patent-licensing growth. Publishing and music businesses...

Already a subscriber? Click here to view full article